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Trypanosoma cruzi metacyclic trypomastigotes invade and replicate in the gastric mucosal epithelium after
oral infection. In this study we analyzed the process of infection by T. cruzi isolates deficient in the expression
of gp82, the metacyclic stage-specific surface glycoprotein implicated in target cell entry in vitro and in
promoting mucosal infection in mice after oral challenge. Mice infected by the oral route with metacyclic forms
of gp82-deficient isolate 569 or 588 developed patent parasitemia but at greatly reduced levels compared to
those infected with the gp82-expressing isolate CL. Metacyclic forms of both isolates expressed gp30, a surface
glycoprotein detectable by monoclonal antibody (MAb) 3F6 directed to gp82. Otherwise, the gp82-deficient
isolates displayed a surface profile similar to that of the CL isolate and also entered epithelial HeLa cells in
a manner inhibitable by MAb 3F6 and dependent on the parasite signal transduction that involved the
activation of protein tyrosine kinase and Ca2 mobilization from thapsigargin-sensitive stores. Like gp82, gp30
triggered the host cell Ca2 response required for parasite internalization. Purified gp30 and the recombinant
gp82 inhibited HeLa cell invasion of metacyclic forms of isolates 569 and 588 by 90 and 70%, respectively.
A cell invasion assay performed in the presence of gastric mucin, mimicking the in vivo infection, showed an
inhibition of 70 to 75% in the internalization of gp82-deficient isolates but not of the CL isolate. The
recombinant gp82 exhibited an adhesive capacity toward gastric mucin much higher than that of gp30. Taken
together, our findings indicate that target cell entry of metacyclic trypomastigotes can be mediated either by
gp82 or gp30 but that efficient mucosal infection depends on the expression of gp82.
Studies performed with Trypanosoma cruzi metacyclic trypo-
mastigotes, the developmental forms that initiate infection in
the mammalian host, have indicated that the stage-specific
surface glycoprotein gp82 mediates mucosal invasion, leading
to systemic T. cruzi infection after oral challenge (17), a route
to which is attributed the microepidemics responsible for more
than half of the acute cases of Chagas’ disease recorded be-
tween 1968 and 2000 in Brazilian Amazon (5). Orally delivered
insect-derived metacyclic forms consistently infect 100% of
BALB/c mice, and evidence has been found that the parasites
invade and replicate in the gastric mucosal epithelium, in con-
trast to the bloodstream trypomastigotes, which rarely initiate
mucosal infection (10, 11).
gp82 appears to be the main metacyclic trypomastigote sur-
face molecule specialized for adhesion to gastric mucin and for
subsequent penetration into underlying epithelial cells. It binds
in vitro to gastric mucin in a dose-dependent manner, where-
as the binding of other surface molecules such as gp90 and
gp35/50 is negligible, and oral administration to BALB/c mice
of metacyclic forms preincubated with monoclonal antibody
(MAb) 3F6, which reacts with gp82 and inhibits target cell
invasion in vitro, greatly reduces parasitemia (17). gp82-medi-
ated binding of metacyclic forms to the host cell induces in
both cells the activation of signal transduction pathways, lead-
ing to intracellular Ca2 mobilization (20, 30), which is a re-
quirement for T. cruzi internalization (7, 14, 23, 28). We have
recently shown that noninfective epimastigotes, which do not
express detectable levels of gp82 and are unable to induce a
Ca2 response, when stably transfected with a T. cruzi expres-
sion vector carrying the metacyclic stage gp82 cDNA, pro-
duced a functional gp82, which bound to and triggered Ca2
responses in HeLa cells (13).
Expression of gp82 has been detected by MAb 3F6 in me-
tacyclic forms of 10 different T. cruzi isolates examined to date
(20) in a survey that did not include isolates from chronically
infected Chagas’ disease patients. Recently we found for the
first time two T. cruzi samples deficient in expression of gp82,
which were isolated from individuals at the chronic phase with
severe clinical manifestations. In the present study we per-
formed a series of in vivo and in vitro experiments to investi-
gate the mechanisms of infection of these gp82-deficient iso-
lates.
MATERIALS AND METHODS
Parasites, mammalian cells, and cell invasion assay. The following T. cruzi
samples were used in this study: 569 (MHOM/BR97/GOCH569), isolated in
1997 by xenodiagnosis from a 59-year-old chronically infected woman with
megaesophagus and megacolon; 588 (MHOM/BR99/GOCH588), isolated in
1999 by xenodiagnosis from a 40-years-old chronically infected man with the
cardiac form of the disease; and CL, from Triatoma infestans (3). T. cruzi samples
569 and 588 were isolated by one of us (A. Luquetti) and were not characterized
before the present study. The parasites were maintained alternately in mice and
in liver infusion tryptose medium. Metacyclic forms, harvested from cultures at
the stationary growth phase, were purified by passage through a DEAE-cellulose
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column, as described previously (25). HeLa cells, a human carcinoma-derived
epithelial cell line, were grown at 37°C in Dulbecco’s minimal essential medium
supplemented with 10% fetal calf serum, streptomycin (100 g/ml), and peni-
cillin (100 U/ml) in a humidified 5% CO2 atmosphere. Experiments on mam-
malian cell invasion by T. cruzi were performed essentially as previously de-
scribed (29).
Oral infection. Purified T. cruzi metacyclic forms were introduced by the
intrapharyngeal route into 4- to 5-week-old female BALB/c mice through a
plastic tube adapted to a 1-ml plastic syringe. Each mouse received 4  105
parasites suspended in phosphate-buffered saline (PBS). Starting on day 13
postinoculation, parasitemia was monitored by twice-weekly phase-contrast mi-
croscopy examination of 5-l peripheral blood samples collected from the tail.
Purification of native and recombinant T. cruzi molecules. To purify the
surface molecule gp30, parasite extracts were prepared by solubilizing metacyclic
trypomastigotes in 1% Nonidet P-40 in the presence of protease inhibitors. After
centrifugation at 12,000 g for 5 min, the supernatant was collected and applied
to the antibody affinity column prepared by coupling MAb 3F6 to CNBr-acti-
vated Sepharose 4B. After 2 h at room temperature with constant shaking, the
resin was packed in a 10-ml plastic syringe and washed several times with PBS.
The bound antigen was eluted with 0.1 M glycine (pH 2.8), neutralized with
Tris-HCl, dialyzed against double-distilled water, vacuum dried, and stored at
20°C until use. Recombinant protein J18, comprising the full-length gp82
sequence in frame with glutathione S-transferase, was generated in Escherichia
coli and purified as described previously (21), by excising from the sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gel the band of
high intensity and of the expected size for the recombinant protein. After elec-
troelution as described previously (27), using a buffer containing 25 mM Tris-
HCl, 192 mM glycine-HCl, and 20% methanol, the sample was dialyzed against
10 mM ammonium bicarbonate for 24 h and thereafter against distilled water for
another 24 h. The purity of the isolated protein was assessed by staining on
SDS-PAGE gel with Coomassie blue, and its specificity was ascertained by
immunoblotting using MAb 3F6.
Antibodies to T. cruzi molecules. Polyclonal monospecific antibodies to gp30 or
to the recombinant protein J18 were generated by immunizing BALB/c mice
intraperitoneally with four doses of the purified molecule (5 g/mouse) plus
A1(OH)3 as adjuvant (0.5 mg/mouse) at 10-day intervals. MAb 3F6, recognizing
gp82 (25), was purified as described previously (19). MAb 1C3, directed to
Leishmania amazonensis gp63 (2), was kindly provided by C. L. Barbieri, Uni-
versidade Federal de Sa˜o Paulo.
FIG. 1. Expression of surface glycoprotein gp30 in T. cruzi isolates 569 and 588. (A) Metacyclic trypomastigotes were analyzed by immuno-
blotting using MAb 3F6. Note the component of 30 kDa recognized by MAb 3F6 in both isolates and the absence of gp82, which is predominant
in isolate CL. Positions of molecular size markers are shown on the left in kilodaltons. (B) Detergent extracts of metacyclic forms of isolate 569
were subjected to treatment with endoglycosidase H, as described in Materials and Methods. The immunoblot with MAb 3F6 shows the conversion
of the 30-kDa molecule into a smaller component, indicating its glycoprotein nature. (C) Live parasites were incubated for 1 h on ice with MAb
3F6 or with unrelated control, MAb 1C3, and processed for analysis by flow cytometry. Note that gp30 is similarly expressed on the surface of
isolates 569 and 588.
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Binding assay of gp30 and gp82 to gastric mucin. The binding assay was
performed using mucin from porcine stomach (type III mucin; Sigma), as fol-
lows: 96-well microtiter plates coated with gastric mucin in PBS (10 g/well) were
blocked for 1 h at room temperature with PBS containing 10% fetal calf serum
(PBS-FCS) and then incubated sequentially, at 37°C for 1 h, with gp30 or with
recombinant gp82, polyclonal monospecific antibody to gp30 or recombinant
gp82, and peroxidase-conjugated anti-mouse IgG, in PBS-FCS. The final reac-
tion was revealed by using o-phenylenediamine as described previously (19).
Immunoblotting and flow cytometry. To analyze the expression of metacyclic
trypomastigote surface molecules by immunoblotting, we used a procedure de-
scribed elsewhere (29). The final reaction was revealed both by chemilumines-
cence, using the ELC Western blotting detection reagent and Hyperfilm-MP
from Amersham, and by using diaminobenzidine plus H2O2. For analysis by flow
cytometry, live metacyclic trypomastigotes (3  107) were incubated for 1 h on
ice with anti-T. cruzi MAb or with unrelated MAb 1C3. After three washings in
PBS, the parasites were fixed with 2% paraformaldehyde in PBS for 30 min. The
fixative was washed out, and the parasites were incubated with fluorescein-
labeled goat anti-mouse immunoglobulin G for 1 h at room temperature. Fol-
lowing two more washes, the number of fluorescent parasites was estimated with
a Becton-Dickinson cytometer.
Enzymatic treatment of parasites. Treatment with endoglycosidase H was
carried out as follows: parasites were lysed with 1% Nonidet P-40 and centri-
fuged at 12,000  g for 5 min, and the supernatant was incubated overnight at
37°C with 1,000 U of endoglycosidase H in 10 denaturing buffer (5% SDS, 10%
-mercaptoethanol) and 10G5 buffer (0.5 M sodium citrate [pH 5.5]) in a total
volume of 50 l. The enzyme-treated samples and the untreated controls were
analyzed by immunoblotting.
Detection of tyrosine-phosphorylated T. cruzi proteins. Parasites (5  107)
were incubated for 20 min at 37°C in the absence or presence of HeLa cell
extract, equivalent to 160 g of protein per ml, in a total volume of 100 l. After
being washed with PBS, the parasites were disrupted at 4°C in a lysis solution (50
mM Tris-HCl [pH 7.4] 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1 mM
NaVO4, 1 mM NaF). Lysates were dissolved in loading buffer and subjected to
electrophoresis in an SDS–10% polyacrylamide gel under reducing conditions,
and the proteins were analyzed by immunoblotting using antiphosphotyrosine
antibodies (Sigma) and chemiluminescence reagent as described previously (8).
Preparation of HeLa cell extract. The cell extracts used in phosphorylation
experiments were prepared as follows. After being washed in PBS, HeLa cells
were detached by scraping, suspended in PBS containing protease inhibitors (1
mM phenylmethylsulfonyl fluoride, 1 mM iodoacetamide, 25 g of leupeptin per
ml, 25 g of antipain per ml), and then sonicated on ice in an XL ultrasonic
processor (two pulses of 30 s each). After disruption of the cells was confirmed
by phase-contrast microscopy, the sonicated preparation was centrifuged at
12,000  g for 5 min and the supernantant was collected and immediately used
for experiments or stored at 80°C until use.
RESULTS
Profile of surface molecules of T. cruzi isolates 569 and 588.
First, metacyclic trypomastigotes of isolates 569 and 588 were
analyzed by Western blotting. A component of 30 kDa was
revealed by MAb 3F6 in both isolates, whereas gp82 was the
predominant molecule recognized by this antibody in isolate
CL (Fig. 1A). gp82 was undetectable in isolate 588 and barely
detectable in isolate 569. To determine whether the MAb 3F6-
reactive 30-kDa molecule was glycosylated, extracts of meta-
cyclic forms of isolate 569 were treated with endoglycosidase
H, an enzyme that specifically cleaves the high-mannose-type
oligosaccharide side chain linked to N-asparagine (24), and
were then analyzed by immunoblotting using MAb 3F6. The
endoglycosidase H treatment fully converted the 30-kDa
FIG. 2. Oral infection of mice with gp82-expressing or gp82-defi-
cient T. cruzi isolates. Each mouse received 4  105 metacyclic trypo-
mastigotes of gp82-expressing isolate CL or gp82-deficient isolate 569.
Each datum point corresponds to the mean parasitemia of six animals
in each group of mice.
FIG. 3. Host cell invasion of gp82-expressing or gp82-deficient
T. cruzi isolates. (A) Metacyclic forms of isolates 569, 588, and CL were
incubated with HeLa cells for 1 h at 37°C, and the intracellular para-
sites in at least 500 Giemsa-stained cells were counted. Values are
means and standard deviations (SD) of six experiments. (B) Parasites
were left untreated or treated for 30 min at room temperature with 500
g of MAb 3F6 per ml or 250 g of the corresponding Fab fragments
per ml before being added to HeLa cells. After a 1-h incubation, the
HeLa cells were washed in PBS and stained with Giemsa. The refer-
ence value of 100% was ascribed to the untreated control. Values are
means and SD of three experiments.
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molecule to a component of 25 kDa (Fig. 1B). Next, we
determined the levels of gp30 on the parasite surface. Live
metacyclic forms were incubated with MAb 3F6 or with iso-
type-matched unrelated MAb 1C3 and processed for analysis
by flow cytometry. Expression of gp30 in isolates 569 and 588
was comparable (Fig. 1C). Neither isolate reacted with MAb
1G7, directed to the metacyclic stage-specific surface molecule
gp90 (25), but they were recognized by MAb 5E7 directed to a
variant gp90 (data not shown). Both reacted with MAb 2B10
but not with MAb 10D8, directed to different epitopes of the
mucin-like glycoprotein gp35/50 (15, 29), thus displaying a
surface profile very similar to that of the gp82-expressing iso-
late CL metacyclic forms (20).
Mucosal infection by gp82-expressing and gp82-deficient
T. cruzi isolates. BALB/c mice received 4  105 metacyclic
forms of isolate 569 or CL by the intrapharingeal route. Start-
FIG. 4. Inhibitory effect of gp30 and recombinant gp82 on host cell invasion of gp82-deficient T. cruzi isolates. Metacyclic forms of isolates 569
and 588 were added to HeLa cells that had been left unincubated or had been preincubated for 15 min with 60 g of native gp30 per ml (A) or
with 80 g of J18 per ml (B), the recombinant protein containing the entire gp82 sequence. After 1 h at 37°C, the intracellular parasites in a total
of at least 500 Giemsa-stained cells were counted. A reference value of 100% was ascribed to the control without the T. cruzi protein. Values are
the means and SD of three experiments performed in duplicate. (C) HeLa cells were preincubted with purified gp30 or J18 at the indicated
concentrations before the addition of metacyclic forms of T. cruzi isolate 569. Representative results of a set of experiments are shown. Values are
the means and SD of triplicate determinations. (D) SDS-PAGE gel containing the extract of T. cruzi isolate 569 (Ext), purified gp30, and molecular
size markers (M), stained with Coomassie blue.
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ing on day 13 postinoculation, 5-l blood samples from indi-
vidual animals were examined twice a week for the presence of
parasites. In mice infected with isolate 569, the parasitemia
levels were very low, in contrast to the animals inoculated with
isolate CL, which developed high parasitemias (Fig. 2). Re-
peated experiments gave essentially the same results. Oral in-
fection of mice with metacyclic forms of isolate 588 also re-
sulted in reduced parasitemias, similar to those produced by
isolate 569 (data not shown). When inoculated by the intra-
peritoneal route into BALB/c mice, metacyclic forms of iso-
lates CL, 569, and 588 produced comparable parasitemia levels
(data not shown).
Host cell invasion by gp82-deficient T. cruzi isolates express-
ing gp30. To determine whether the metacyclic forms of iso-
lates 569 and 588 differed from the CL isolate in their ability to
enter host cells, we performed cell invasion assays by incubat-
ing the parasites with HeLa cells at 37°C for 1 h. Following
washes in PBS, HeLa cells were stained with Giemsa and the
intracellular parasites in at least 500 cells were counted. As
shown in Fig. 3, the infectivity of the three isolates was com-
parable and their internalization was similarly diminished
when they were treated with MAb 3F6, suggesting that gp30 is
involved in target cell invasion of gp82-deficient T. cruzi iso-
lates. Compatible with this view, the native gp30 exhibited a
Ca2-signaling activity toward HeLa cells similar to that of the
native gp82 (data not shown). Furthermore, penetration of
metacyclic forms of isolates 569 and 588 into HeLa cells was
inhibited by ca. 90% in the presence of purified gp30 at 60
g/ml (Fig. 4A) and by ca. 70% in the presence of the recom-
binant gp82 at 80 g/ml (Fig. 4B). Even at a concentration as
low as 2.5 g/ml, gp30 still displayed some inhibitory effect
(Fig. 4C). Although to a lesser degree, HeLa cell entry of
isolate CL metacyclic forms was also reduced by gp30, with
inhibition of ca. 80% and ca. 55%, respectively, at gp30 con-
centrations of 60 and 30 g/ml. As judged by the purity of gp30,
determined by Coomassie blue staining of an SDS-PAGE gel
(Fig. 4D), the possibility that eventual contaminant proteins
contributed to the observed effect of gp30 appears to be min-
imal.
Signal transduction in gp82-deficient T. cruzi isolates dur-
ing host cell invasion. Previous studies with isolate CL have
shown that target cell invasion requires the activation of the
parasite protein tyrosine kinase (PTK), which is triggered by
gp82 binding to its receptor (8, 16, 30). To determine the
association between PTK activation and infectivity of metacy-
clic forms of gp82-deficient T. cruzi isolates, we examined the
effect of genistein, a specific inhibitor of PTK which scarcely
inhibits the enzyme activities of serine- and threonine-specific
protein kinases (1). Metacyclic forms of 569 and 588 isolates
were treated at 37°C for 30 min with 250 M genistein. After
being washed in PBS, control and genistein-treated parasites
were incubated with HeLa cells for 30 min at 37°C. Figure 5A
shows that the ability of genistein-treated parasites to invade
HeLa cells was significantly diminished. In isolate CL, PTK
mediates the phosphorylation of a 175-kDa protein (p175) in a
manner inducible by soluble extract of HeLa cells (8). We
assayed the presence of HeLa cell-inducible p175 in isolates
569 and 588. Metacyclic trypomastigotes were incubated in the
absence or presence of HeLa cell extract for 20 min at 37°C.
After being washed in PBS, the parasites were disrupted by
adding 1% Triton X-100 solution containing phosphatase in-
hibitors. Whole lysates were then analyzed by Western blotting
using antiphosphotyrosine antibodies. Similarly to what is seen
in isolate CL, the phosphorylation levels of p175 were aug-
mented by the parasite-host cell interaction (Fig. 5B). The
differences in the intensity of p175 bands in different samples
are not due to an eventual unequal loading, because we ascer-
tained that equal amounts of parasite extracts were loaded,
either by staining the SDS-PAGE gel with Coomassie blue or
by staining the nitrocellulose membrane with Ponceau-S.
FIG. 5. Effect of inhibition of parasite PTK and Ca2 mobilization
on host cell invasion by gp82-deficient T. cruzi isolates. (A) Metacyclic
forms of isolates 569 and 588, pretreated () or not pretreated ()
with the PTK inhibitor genistein, were incubated with HeLa cells at
37°C for 30 min. After the cells were washed in PBS, the intracellular
parasites in at least 500 Giemsa-stained cells were counted. The values
are the means and SD of three experiments performed in duplicate.
(B) Parasites were incubated for 20 min at 37°C in the absence () or
presence () of HeLa cell extract, washed with PBS, and processed for
immunoblotting using antiphosphotyrosine antibodies. Note the in-
crease in p175 phosphorylation levels in parasites exposed to HeLa cell
extract. (C) Metacyclic forms were either untreated or treated with 1
M thapsigargin before being incubated with HeLa cells for 30 min.
Values are the means and SD of three experiments performed in
duplicate.
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Ca2 mobilization in the parasite is a requisite for cell in-
vasion (14, 20, 28). Experiments with metacyclic forms of iso-
late CL have shown that HeLa cell entry is inhibited by treat-
ment of parasites with thapsigargin, a sesquiterpene lactone
that depletes intracellular Ca2 stores in many mammalian cell
types by specific inhibition of endoplasmic reticulum Ca2-
ATPase (26). We treated metacyclic trypomastigotes of iso-
lates 569 and 588 with 1 M thapsigargin at 37°C for 30 min
before using them to seed HeLa cells. Compared to untreated
controls, the ability of thapsigargin-treated parasites to invade
HeLa cells was significantly diminished (Fig. 5C).
Effect of gastric mucin on host cell entry of gp82-deficient
T. cruzi isolates. The finding that the in vivo infectivity of
metacyclic forms of gp82-deficient isolates differs from that of
the gp82-expressing isolate CL (Fig. 2), although no apparent
difference was seen in vitro (Fig. 3A), led us to consider the
possibility that mucin, the protective coat that lines gastroin-
testinal mucosal surfaces, could be affecting the interaction of
gp82-deficient parasites with the underlying epithelial cells. In
an attempt to mimic the in vivo mucosal infection, we per-
formed HeLa cell invasion assays in the presence of gastric
mucin at 20 mg/ml. The internalization of metacyclic forms of
isolates 569 and 588, but not of CL, was diminished by about 70
to 75% in the presence of mucin (Fig. 6A).
Inefficient binding of gp30 to gastric mucin. gp82, either as
the native molecule or as the recombinant protein, was found
to bind to gastric mucin in vitro (17). Since this property may
be associated with the efficient mucosal infection by gp82-
expressing metacyclic forms of isolate CL, we examined the
adhesive capacity of gp30 towards gastric mucin. Using anti-
gp82 polyclonal antibodies, which cross-react with gp30, we
found poor gp30 binding to mucin, in contrast to J18, the
recombinant gp82 (Fig. 6B). The binding assay using anti-gp30
antibodies gave essentially the same results.
DISCUSSION
In this study, we performed the first analysis of T. cruzi
isolates deficient in the expression of gp82, the metacyclic
stage-specific surface molecule that appears to promote mu-
cosal infection by mediating parasite penetration into host
epithelial cells (17).
Metacyclic trypomastigotes of T. cruzi isolates 569 and 588,
deficient in gp82, were found to express gp30, a surface glyco-
protein recognized by MAb 3F6 (Fig. 1). Otherwise, these
isolates displayed a surface profile similar to that of the gp82-
expressing isolate CL. The abilities of metacyclic forms of
isolates 569, 588, and CL to invade HeLa cells were similar and
were inhibited similarly by MAb 3F6 (Fig. 3B). The fact that
both gp30 and J18, the recombinant gp82, can significantly
reduce the internalization of metacyclic forms of isolates 569
and 588 (Fig. 4), in addition to the inhibitory effect of gp30 on
isolate CL infectivity, suggests that gp30 and gp82 are possibly
recognized by a common target cell receptor. In this regard, it
is significant that gp30 induced a Ca2 response in HeLa cells
in the same manner as gp82. It is possible that gp30 and gp82
have in common the host cell adhesion site, which in gp82 is
located downstream of and contiguous to MAb 3F6-epitope
(12). Target cell invasion of gp82-deficient metacyclic trypo-
mastigotes requires parasite PTK activation (Fig. 5A) and re-
lease of Ca2, at least in part, from thapsigargin-sensitive
stores (Fig. 5C). In isolate CL metacyclic forms, Ca2 is also
mobilized in a thapsigargin-susceptible manner during cell in-
vasion, and this Ca2 response is associated with PTK activa-
tion induced by gp82-mediated attachment to host cells (30).
We also found that, as in isolate CL, the substrate for PTK in
569 and 588 isolates is p175 (Fig. 5B), a component that is
undetectable in noninfective epimastigote forms and is specif-
ically phosphorylated on interaction of infective trypomastig-
FIG. 6. Differential interaction of T. cruzi metacyclic-stage surface molecule gp30 and 82 with gastric mucin. (A) Gastric mucin at 20 mg/ml was
added to HeLa cells 15 min before they were incubated with metacyclic trypomastigotes. After a 1-h incubation, the cells were washed, fixed, and
stained for intracellular parasite counting. The values are the means and SD of three experiments performed in duplicate. (B) J18, the recombinant
gp82, or purified gp30 at 10 g/ml was added to microtiter plates coated with porcine gastric mucin. After being washed, the plates were
sequentially incubated with anti-J18 antibody and anti-mouse immunoglobulin conjugated to peroxidase. The bound enzyme was revealed using
o-phenylenediamine. The values are the means and SD of triplicate samples. O.D.492, optical density at 492 nm.
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otes with T. cruzi-susceptible, but not with T. cruzi-resistant,
target cells (8). Taken together, these observations indicate
that gp82- and gp30-expressing T. cruzi isolates use a similar
mechanism to invade host cells.
We have recently shown that metacyclic forms of isolates G
and CL, which belong to the two highly divergent phylogenetic
lineages T. cruzi I and II, respectively (4), use distinct signal
transduction pathways to enter host cells (16). In isolate G
(T. cruzi I), PTK appears to play no role and the Ca2 required
for parasite internalization is released from acidic vacuoles
containing a Ca2/H exchange system (16), described by Do-
campo et al. (6). The finding that T. cruzi isolates 569 and 588,
like isolate CL, use the PTK-dependent signaling pathway for
host cell penetration is consistent with the fact that they are all
T. cruzi II parasites.
Although the metacyclic forms of gp82-deficient and gp82-
expressing T. cruzi isolates apparently use similar mechanims
to invade epithelial cells, when we compared their capacity to
produce systemic infection after oral challenge, we observed
marked difference. In contrast to infection by gp82-expressing
isolate CL, which results in high parasitemias, mice inoculated
orally with gp82-deficient metacyclic forms of isolate 569 de-
veloped low parasitemias (Fig. 2). Moreover, mortality (10 to
20%) has been observed among mice inoculated with isolate
CL but not among those isolated with isolate 569 or 588. It is
possible that this difference is due to the differential capacity of
gp82 and gp30 to bind to gastric mucin. Unlike gp82, gp30
bound to mucin very poorly (Fig. 6B). If the gp82-mediated
interaction with mucin is the first step in the penetration of
metacyclic trypomastigotes into the underlying epithelial cells,
the gp82-deficient parasites would have difficulty in penetrat-
ing the thick mucin coat that lines the gastrointestinal mucosal
surfaces. Shigella dysenteriae, for instance, whose pathogenic
potential is correlated with its ability to invade and multiply
within the cells of the colonic epithelium, preferentially ad-
heres to colonic mucin (22). The observation that the presence
of gastric mucin impairs HeLa cell invasion of metacyclic forms
of gp82-deficient isolates, but not of gp82-expressing isolate
CL (Fig. 6A), reinforces the role played by gp82 in mucosal
infection. In T. cruzi developmental forms circulating in the
bloodstream, the surface molecules that bind to components of
the extracellular matrix would be playing a role analogous to
that of the metacyclic-stage gp82. Molecules implicated in cell
invasion, such as the laminin-binding Tc-85 (9) and penetrin,
which has affinity for heparin, heparan sulfate and collagen
(18), would help the parasites to traverse the extracellular
matrices and basal laminae to reach the target cells. Overall,
our results indicate that gp30 is implicated in host cell invasion
of gp82-deficient metacyclic trypomastigotes but fails to pro-
mote an efficient mucosal infection due to its deficient inter-
action with gastric mucin.
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